[DOI] [PMC free article] [PubMed] 292.Castilla-Cortzar I, Aliaga-Montilla MA, Salvador J, Garca M, Delgado G, Gonzlez-Barn S, Quiroga J, Prieto J
The use of TRESIBA for this indication is supported by evidence from an adequate and well-controlled trial and a pharmacokinetic study (trials included pediatric patients 1 year of age and older with type 1 diabetes mellitus) [see Clinical Pharmacology (12.3) and Clinical Studies (14.2)]
I had one patient tell me that its like, changed her relationship to food, Rom said
After your first injection, the medication enters your bloodstream and starts binding to GLP-1 receptors in multiple tissues, including the pancreas, gastrointestinal tract, and brain